Filtration In Biopharmaceutical Development & Manufacturing

 

Pharmaceutical formulations, drug products, therapies, vaccines and the processes by which they are made are becoming increasingly diverse. Whether used for clarification or sterilization of final material, filtration remains an essential part of them.

 

In this presentation, Tom Watson talks about Pall’s range of filters including carbon removal filters, sterilizing grade filters (liquid and air/gas applications) and pre-filters for different types of drugs and manufacturing processes.

 

You will also understand how Pall Biotech is continuing to innovate in the field of prefiltration and sterilizing grade filtration in response to evolving regulatory standards and changes in drug classes.

 

Participants will learn about:

 

  • How to select a right filter for your product and process.
  • What’s new in the pre-filtration and sterilizing grade filtration.
  • Integrity testing of hydrophilic and hydrophobic filters.

Speaker

tom watson

Tom Watson

Global Product Manager, Sterilizing Grade Filters

Pall Biotech

 

Tom joined Pall in 2003, having graduated from the University of Sheffield, UK with a degree in Biotechnology and Microbiology. Following several years as an Account Manager, in 2010 he joined the Global Product Marketing first as Global Product Manager, Sterilizing-grade Filters and is now marketing group leader for Sterilizing grade filters, test instruments and systems.

Filtration In Biopharmaceutical Development & Manufacturing

icon image

Prepare for a Successful Validation of Liposome-Based Drugs

Download this guide to get recommendations for applying QbD principles for sterility assurance during aseptic processing

더 Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
May 2021
Overcome Exosome Production Challenges

Biotech | Pall Corporation 웨비나 시리즈

This webinar was recorded by BioPharma Asia and first published on their website. https://biopharma-asia.com. It is made available here by kind permission of BioPharma Asia and the presenters. Scroll down to see a transcript of the webinar question and answer session.

 

Hailed as the “next frontier” in cell therapy and regenerative medicine, exosomes are a type of extracellular vesicle and play a key role in the regulation of the intercellular communication processes.

David Haylock of VivaZome will present on upstream production of angiogenic exosomes using the iCELLis® nano fixed bed bioreactor. This will be followed by a presentation by Roberto Ciboldi of Pall Corporation on a platform solution including cell culture, purification and sterile filtration of exosomes.

Participants will be able to:

 

  • Compare the performance of the iCELLis Nano bioreactor to traditional flasks for exosome production from adherent cell culture
  • Understand how an integrated end to end platform delivers highly   purified and consistently-sized exosomes
  • Discover an innovative cGMP scalable manufacturing platform for   exosomes
시청